未登录
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏Active and machine learning-enhanced discovery of new FGFR3 inhibitor, Rhapontin, through virtual screening of receptor structures and anti-cancer activity assessment
Zeng, Qingxin; Hu, Haichuan; Huang, Zhengwei; Guo, Aotian; Lu, Sheng; Tong, Wenbin; Zhang, Zhongheng; Shen, Tao
分享
收藏Correlation analysis between driver gene mutation and clinicopathological features in lung adenocarcinoma based on real-world cumulative clinical data基于真实世界累积临床数据的肺腺癌驱动基因突变与临床病理特征的相关性分析
Lu, Sheng; Guo, Aotian; Hu, Haichuan; Ying, Xinxin; Li, Yao; Huang, Zhengwei; Xu, Wangjue; Tao, Shen; Hu, Xiaotong; Yan, Na; Zhang, Xuan; Shen, Dan; Sasaki, Takaaki; Arulananda, Surein; Onodera, Ken; He, Zhengfu
分享
收藏Discovery of 5-(Pyrimidin-2-ylamino)-1H-indole-2-carboxamide Derivatives as Nur77 Modulators with Selective and Potent Activity Against Triple-Negative Breast Cancer
Qin, Jingbo; Niu, Boning; Chen, Xiaohui; Hu, Cheng; Lu, Sheng; Li, Hongsheng; Liu, Weihao; Li, Jiayi; Teng, Zihao; Yang, Yinghuang; Hu, Hongyu; Xu, Yang; Huo, Shuaidong; Wu, Zhen; Qiu, Yingkun; Zhou, Hu; Fang, Meijuan
分享
收藏The novel CDK9 inhibitor, XPW1, alone and in combination with BRD4 inhibitor JQ1, for the treatment of clear cell renal cell carcinoma
Kuang, Zhijian; Guo, Kaiqiang; Cao, Yin; Jiang, Mengxue; Wang, Chaojie; Wu, Qiaoqiong; Hu, Guosheng; Ao, Mingtao; Huang, Mingfeng; Qin, Jingbo; Zhao, Taige; Lu, Sheng; Sun, Cuiling; Li, Mingyu; Wu, Tong; Liu, Wen; Fang, Meijuan
分享
收藏